Watch for the prospectus supplement to disclose offering size and pricing, which will determine dilution magnitude. The Nov 30 deadline for the Perceptive amendment conditions is the next catalyst; failure to close the offering or meet conditions would leave going concern risk unresolved.
STIM drugs
STIM drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $1.62entry
- T+1 · 5d ago −11.73%α −11.37% · $1.43
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Neuronetics announced an underwritten public offering of common stock, with proceeds expected to prepay $15M of its Perceptive credit facility to reduce revenue covenants and resolve the going concern risk. The offering size and pricing are undisclosed, creating dilution uncertainty for existing shareholders.
Key Facts
- Neuronetics commenced an underwritten public offering of common stock; all shares sold by the company.
- Underwriters have a 30-day option to purchase up to an additional 15% of the offered shares.
- Proceeds are expected to prepay at least $15M of the Perceptive credit facility to satisfy conditions for Amendment No. 6.
- The Perceptive Sixth Amendment reduces certain revenue covenants and, if conditions are met by Nov 30, 2026, is intended to resolve the going concern risk.
- William Blair is lead bookrunner; BTIG and Canaccord Genuity are additional bookrunners.
- The offering is made under an existing effective shelf registration statement (S-3).
Financial Impact
Undisclosed offering size; at least $15M of proceeds earmarked for debt prepayment. Dilution percentage unknown until pricing.
Risk Factors
- Offering size and pricing are undisclosed; dilution could be significant relative to the $167M market cap.
- If the offering does not close or conditions are not met by Nov 30, the Perceptive Sixth Amendment terminates and going concern risk remains.
- The company has a history of losses and negative cash flow, adding execution risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3400185 |
Track record
30 reports on STIM
6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +11.73% at T+1 after the Nov 10, 2026 report. 7 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13D/A Neutral 4/10 Entry price pending
- Nov 16, 2026today SC 13D/A Bearish 6/10 Entry price pending
- Nov 12, 20264d ago 8-K/A Bearish 5/10 Entry $1.39 to $1.25 Now $1.25 +10.07% ▲ +10.07% +8.16% vs SPY
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
- Nov 12, 20264d ago 424B5 Bearish 6/10 Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
- Nov 10, 20265d ago Press Release Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 424B5 Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.62 to $1.43 Now $1.25 −22.84% ▼ −11.73% −11.37% vs SPY
- Nov 10, 20266d ago Press Release Bearish 6/10 Viewing Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $2.01 to $1.62 Now $1.25 −37.81% ▼ −19.40% −20.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers